Stay updated with breaking news from Haemonetics Daily. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Peregrine Capital Management LLC trimmed its stake in shares of Haemonetics Co. (NYSE:HAE – Free Report) by 14.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 110,313 shares of the medical instruments supplier’s stock after selling 18,094 shares during […]
Peregrine Capital Management LLC lowered its stake in shares of Haemonetics Co. (NYSE:HAE – Free Report) by 14.1% in the fourth quarter, Holdings Channel.com reports. The firm owned 110,313 shares of the medical instruments supplier’s stock after selling 18,094 shares during the period. Peregrine Capital Management LLC’s holdings in Haemonetics were worth $9,433,000 as of […]
Haemonetics Co. (NYSE:HAE – Free Report) – Zacks Research lifted their Q1 2025 EPS estimates for shares of Haemonetics in a report issued on Thursday, March 28th. Zacks Research analyst R. Department now expects that the medical instruments supplier will post earnings of $0.94 per share for the quarter, up from their prior estimate of […]
Haemonetics (NYSE:HAE – Get Free Report) issued its quarterly earnings data on Thursday. The medical instruments supplier reported $1.04 EPS for the quarter, beating the consensus estimate of $0.94 by $0.10, Briefing.com reports. Haemonetics had a return on equity of 22.37% and a net margin of 9.97%. The company had revenue of $336.20 million for […]
Haemonetics Co. (NYSE:HAE – Get Free Report) gapped up prior to trading on Thursday after the company announced better than expected quarterly earnings. The stock had previously closed at $77.11, but opened at $81.26. Haemonetics shares last traded at $78.45, with a volume of 398,865 shares. The medical instruments supplier reported $1.04 EPS for the […]